{"product_id":"mailishudenosumab-мэйлишу-деносумаб","title":"MAILISHU(Denosumab)                Мэйлишу (деносумаб)","description":"\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eMAILISHU (Denosumab)\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e is a medicine containing \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003edenosumab\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e as its active ingredient. Denosumab is a monoclonal antibody that binds to and inhibits RANKL, a protein involved in the formation and activity of osteoclasts.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eIndications:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Denosumab is used for certain bone-related conditions, including reducing the risk of fractures in patients with osteoporosis and preventing skeletal-related complications in some patients with cancer affecting the bones. Specific indications depend on the dosage and approved product labeling.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eDosage form:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Solution for subcutaneous injection, typically supplied in a pre-filled syringe or vial, depending on the product.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eAdministration:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Administered \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003esubcutaneously\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e according to the physician's prescribed dosing schedule. The dose and frequency depend on the indication.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003ePossible adverse effects:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e These may include hypocalcemia, infections, skin reactions, muscle and joint pain. Rare but serious adverse effects may include osteonecrosis of the jaw and atypical femoral fractures.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eImportant:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Calcium levels should be assessed before treatment, and adequate calcium and vitamin D intake may be recommended. Denosumab is a prescription medicine and should be used under appropriate medical supervision.\u003c\/span\u003e\u003c\/p\u003e","brand":"XOMEDS","offers":[{"title":"Default Title","offer_id":45404091547691,"sku":null,"price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/images_3_407dc554-8881-4b33-a427-08f1cd3419b8.jpg?v=1789725739","url":"https:\/\/xomeds.com\/products\/mailishudenosumab-%d0%bc%d1%8d%d0%b9%d0%bb%d0%b8%d1%88%d1%83-%d0%b4%d0%b5%d0%bd%d0%be%d1%81%d1%83%d0%bc%d0%b0%d0%b1","provider":"XOMEDS","version":"1.0","type":"link"}